Category: St. Jude Medical
St. Jude Medical says the FDA approved its Ilumien Optis device, designed to measure blood flow and provide images of the heart during stenting procedures.
St. Jude Medical (NYSE:STJ) said today that the FDA granted pre-market approval for its next-generation Ilumien Optis device, which combines a pair of technologies to help guide physicians during stenting procedures.
St. Jude Medical wants a federal judge in Minnesota to toss a shareholders class action lawsuit filed against the medical device company and its management.
St. Jude Medical (NYSE:STJ) wants a federal judge in Minnesota to toss a class action lawsuit filed by shareholders after the medical device company's stock took a dive in 2009 when it reduced its guidance.
The FDA warns that, in rare cases, St. Jude Medical's Amplatzer atrial septal occluder may erode tissue in the heart, creating holes that require open-heart surgery to mend.
Updated October 17, 2013, at 5 p.m.
Shares of St. Jude Medical gain in early-morning trading after the medical device company beats Wall Street's sales and earnings expectations and increases its outlook for the rest of the year.
St. Jude Medical (NYSE:STJ) shares gained in early-morning trading today after the medical device company said it beat Wall Street's expectations for sales and earnings and boosted its outlook for the rest of 2013.
Shares of St. Jude Medical jump on news of its buyout of Nanostim following European approval of its leadless pacemaker.
St. Jude Medical (NYSE:STJ) shares gained 1.6% after the medical device company said it acquired Nanostim and its miniature leadless pacemaker following European approval of the device.
St. Jude CEO Daniel Starks says his rivals' laser-focus on cheaper medical devices for emerging markets puts too much stake in the present rather than looking to the future.
St. Jude Medical (NYSE:STJ) CEO Daniel Starks has his own key to success, and it doesn't jibe well with some of his rivals, who he left unnamed in his criticism.
The keys to a huge payoff in the medical device industry are cost-cutting technologies and those that target the right disease states, according to St. Jude CEO Daniel Starks.
MASSDEVICE ON CALL — The medical device industry has some pretty big hurdles to face, but companies can still land big wins if they can hit the market's "sweet spot", according to St. Jude Medical (NYSE:STJ) CEO Daniel Starks.